Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism

Journal of the Neurological Sciences

Volumn 215, Issue 1-2, 2003, Pages 51-55

  Paraskevas, George P ^a   Kapaki, Elisabeth ^a   Petropoulou, Olga ^a   Anagnostouli, Maria ^a   Vagenas, Vasileios ^b   Papageorgiou, Constantine ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b First Hosp of the Social Ins Inst   (Greece)

Author keywords

Ascorbate; Parkinson's disease; Retinol; Tocopherol; Vascular parkinsonism; Vitamin A; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0142026191     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00184-9     Document Type: Article

References (48)

1. Dugan L.L., Choi D.W. Excitotoxicity, free radicals and cell membrane changes. Ann. Neurol. 35:1994;S17-S21.
2. Jenner P., Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44(Suppl. 1):1998;S72-S84.
3. Niki E. Vitamin C as an antioxidant. World Rev. Nutr. Diet. 64:1991;1-31.
4. Grünewald R.A. Ascorbic acid in the brain. Brain Res. Rev. 18:1993;123-133.
5. Niki E., Yamamoto Y., Takahashi M.et al. Inhibition of oxidation of biomembranes by tocopherol. Diplock A.T., Machlin L.J., Packer L., Pryor W.A. Vitamin E: biochemistry and health implications. vol. 570:1989;23-31 Ann. NY Acad. Sci. New York.
6. Das N.P. Effects of vitamin A and its analogs on nonenzymatic lipid peroxidation in rat brain mitochondria. J. Neurochem. 52:1989;585-588.
7. Senarath-Yapa S.C. Detection of subclinical ascorbate deficiency in early Parkinson's disease. Public Health. 106:1992;393-395.
8. Singh R.B., Niaz M.A., Grosh S.et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease. A hospital-based case-control study. J. Nutr. Environ. Med. 5:1995;235-242.
9. Férnandez-Calle P., Jiménez-Jiménez F.J., Molina J.A.et al. Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease. J. Neurol. Sci. 118:1993;25-28.
10. King D., Playfer J.R., Roberts M.B. Concentrations of vitamins A, C and E, in elderly patients with Parkinson's disease. Postgrad. Med. J. 68:1992;634-637.
11. Logroscino G., Marder K., Cote L.et al. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-controlled study. Ann. Neurol. 39:1996;89-94.
12. DeRijk M.C., Breteler M.M.B., den Breeijen J.H.et al. Dietary antioxidants and Parkinson's disease. Arch. Neurol. 54:1997;762-765.
13. Férnandez-Calle P., Molina J.A., Jiménez-Jiménez F.J. Serum levels of α-tocopherol (vitamin E) in Parkinson's disease. Neurology. 42:1992;1064-1066.
14. Hellenbrand W., Boeing H., Robra B.-P.et al. Diet and Parkinson's disease: II. A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology. 47:1996;644-650.
15. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
16. Riemersma R.A., Wood D.A., Macintyre C.C.A.et al. Low plasma vitamins E and C. Increased risk of angina in Scottish men. Diplock A.T., Machlin L.J., Packer L., Pryor W.A. Vitamin E: biochemistry and health implications. vol. 570:1989;291-295 Ann. NY Acad. Sci. New York.
17. Foltynie T., Barker R., Brayne C. Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology. 21:2002;1-7.
18. Winikates J., Jancovic J. Clinical correlates of vascular parkinsonism. Arch. Neurol. 56:1999;98-102.
19. Demirkiran M., Bozdemir H., Sarica Y. Vascular parkinsonism: a distinct heterogeneous clinical entity. Acta Neurol. Scand. 104:2001;63-67.
20. Jellinger K.A. Vascular parkinsonism - neuropathological findings. Acta Neurol. Scand. 105:2002;414-415.
21. Riley D.E., Lang A.E. Non-Parkinson akinetic-rigid syndromes. Curr. Opin. Neurol. 9:1996;321-326.
22. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria of Parkinson's disease. Arch. Neurol. 56:1999;33-39.
23. Larsen J.P., Dupont E., Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol. Scand. 89:1994;242-251.
24. Gilman S., Low P.A., Quinn N.et al. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 163:1999;94-98.
25. Litvan I., Agid Y., Calne D.et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 47:1996;1-9.
26. Paraskevas G.P., Kapaki E., Libitaki G.et al. Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurol. Scand. 96:1997;88-90.
27. Dexter D.T., Ward R.J., Wells F.R.et al. α-Tocopherol levels in brain are not altered in Parkinson's disease. Ann. Neurol. 32:1992;591-593.
28. Molina J.A., De Bustos F., Jimenez-Jimenez F.J.et al. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease. J. Neural Transm. 104:1997;1287-1293.
29. Riederer P., Sofic E., Rausch W.D.et al. Transision metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:1989;515-520.
30. Church W.H., Ward V.L. Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation. Brain Res. Bull. 33:1994;419-425.
31. Paraskevas G.P., Kapaki E., Zournas C.et al. Copper and ascorbate in Parkinson's disease. Proceedings Book of the "International Symposium on Trace Elements in Human: New Perspectives". Athens. 1997;559-568.
32. Chiueh C.C., Miyake H., Peng M.T. Role of dopamine autooxidation, hydroxyl radical generation and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Narabayashi H., Nagatsu T., Yanagisawa N., Mizuno Y. Advances in neurology. Parkinson's disease. vol. 60:1993;251-258 Raven Press, New York.
33. Li C.L., Werner P., Cohen G. Lipid peroxidation in brain: interaction of L-dopa/dopamine with ascorbate and iron. Neurodegeneration. 4:1995;147-153.
34. Albers D.S., Augood S.J., Park L.C.et al. Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. J. Neurochem. 74:2000;878-881.
35. Simon J.A., Hudes E.S., Browner W.S. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiology. 9:1998;316-321.
36. Gey K.F., Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Diplock A.T., Machlin L.J., Packer L., Pryor W.A. Vitamin E: biochemistry and health implications. vol. 570:1989;268-282 Ann. NY Acad. Sci. New York.
37. Knekt P., Reunanen A., Jarvinen R.et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139:1994;1180-1189.
38. Pierdomenico S.D., Costantini F., Bucci A.et al. Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension. Hypertension. 31:1998;621-626.
39. Tse W.Y., Maxwell S.R., Thomason H.et al. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J. Hum. Hypertens. 8:1994;843-849.
40. Sharpe P.C., Mulholland C., Trinick T. Ascorbate and malondialdehyde in stroke patients. Ir. J. Med. Sci. 163:1994;488-491.
41. Schmidt R., Fazekas F., Hayn M.et al. Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study. J. Neurol. Sci. 152:1997;15-21.
42. Hirano R., Kondo K., Iwamoto T.et al. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein. J. Nutr. Sci. Vitaminol. 43:1997;435-444.
43. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB. 8:1994;1279-1284.
44. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipidol. 5:1994;422-433.
45. 2 and arterial prostacyclin by dietary vitamin E. Prostaglandins. 22:1981;651-661.
46. Fukuzawa K., Kurotori Y., Tokumura A., Tsukatani H. Increased platelet-activating factor (PAF) synthesis in polymorphonuclear leucocytes of vitamin E-deficient rats. Diplock A.T., Machlin L.J., Packer L., Pryor W.A. Vitamin E: biochemistry and health implications. vol. 570:1989;449-454 Ann. NY Acad. Sci. New York.
47. Chang J.Y., Liu L.Z. Neurotoxicity of cholesterol oxides on cultured cerebellar granule cells. Neurochem. Int. 32:1998;317-323.
48. Chang J.Y., Phelan K.D., Chavis J.A. Neurotoxicity of 25-OH-cholesterol on sympathetic neurons. Brain Res. Bull. 45:1998;615-622.